Consensus Fulgent Genetics, Inc.

Equities

FLGT

US3596641098

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
20.1 ^USD	+0.35%		-1.28%	-30.47%

Mar. 06	Piper Sandler Adjusts Price Target on Fulgent Genetics to $25 From $28, Maintains Neutral Rating	MT
Feb. 29	UBS Adjusts Fulgent Genetics Price Target to $25 From $35, Maintains Neutral Rating	MT

Evolution of the average Target Price on Fulgent Genetics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

57e9b8a242f24.7BUA9Mr05OzKgQ8FktMaP7MRiEG7rjEfZvCtF5cOmQ0.nSZBp63ClLSzxFpB55p9Sd1C2xT5n2NxN7r6dtZK1V-dTzC1hZvdn53rXg~156e1f35aa08455d70655c2d749dd8eb

Analyst Recommendations on Fulgent Genetics, Inc.

Piper Sandler Adjusts Price Target on Fulgent Genetics to $25 From $28, Maintains Neutral Rating	Mar. 06	MT
UBS Adjusts Fulgent Genetics Price Target to $25 From $35, Maintains Neutral Rating	Feb. 29	MT
UBS Initiates Coverage on Fulgent Genetics With Neutral Rating, $35 Price Target	Dec. 07	MT
Fulgent Genetics Swings to Loss in Q2, Revenue Declines; Raises Guidance; Shares Surge 10% Pre-Bell	23-08-04	MT
Credit Suisse Lowers Fulgent Genetics' Price Target to $45 From $50 After Mixed Q4 Results, Keeps Outperform Rating	23-03-02	MT
Piper Sandler Downgrades Fulgent Genetics to Neutral From Overweight, Adjusts Price Target to $40 From $65	22-12-08	MT
Raymond James Starts Fulgent Genetics at Outperform With $45 Price Target	22-11-18	MT
Piper Sandler Adjusts Price Target on Fulgent Genetics to $65 From $70, Maintains Overweight Rating	22-11-14	MT
Credit Suisse Adjusts Fulgent Genetics' Price Target to $50 From $65, Keeps Outperform Rating	22-11-14	MT
Credit Suisse Initiates Fulgent Genetics at Outperform with $65 Price Target	22-08-25	MT
Piper Sandler Adjusts Fulgent Genetics' Price Target to $70 From $85, Reiterates Overweight Rating	22-05-16	MT
Oppenheimer Adjusts Fulgent Genetics Price Target to $112 From $123, Maintains Outperform Rating	22-05-04	MT
Piper Sandler Adjusts Fulgent Genetics' Price Target to $85 From $80, Reiterates Overweight Rating	22-03-01	MT
Oppenheimer Adjusts Fulgent Genetics Price Target to $123 From $125, Maintains Outperform Rating	22-02-24	MT
Piper Sandler Assumes Fulgent Genetics at Overweight with $80 Price Target	22-02-04	MT
Oppenheimer Adjusts Fulgent Genetics' Price Target to $125 From $141, Maintains Outperform Rating	22-01-25	MT
FULGENT GENETICS : Credit Suisse Adjusts Fulgent Genetics' Price Target to $65 from $55, Keeps Underperform Rating	21-08-10	MT
FULGENT GENETICS : Oppenheimer Adjusts Fulgent Genetics PT to $141 From $118, Maintains Outperform Rating	21-08-10	MT
FULGENT GENETICS : Oppenheimer Adjusts Fulgent Genetics PT to $118 From $126, Maintains Outperform Rating	21-05-07	MT
FULGENT GENETICS : Oppenheimer Adjusts Fulgent Genetics PT to $126 From $130 on Q1 Preview, Maintains Outperform Rating	21-04-07	MT
FULGENT GENETICS : Piper Sandler Adjusts Price Target on Fulgent Genetics to $140 From $135, Maintains Overweight Rating	21-03-05	MT
FULGENT GENETICS : Credit Suisse Raises Fulgent Genetics' Price Target to $49 from $40 on Upbeat Q4 2020 Earnings, Keeps Underperform Rating	21-03-05	MT
FULGENT GENETICS : Oppenheimer Adjusts Fulgent Genetics' Price Target to $130 From $75, Maintains Outperform Rating	21-02-01	MT
FULGENT GENETICS : Credit Suisse Downgrades Fulgent Genetics' Price Target to Underperform From Neutral	21-01-08	MT
FULGENT GENETICS : BTIG Downgrades Fulgent Genetics to Neutral From Buy	20-11-24	MT